Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hematopoietic and Lymphoid System Neoplasm: early-phase trial registry
21 of 32 indexed Hematopoietic and Lymphoid System Neoplasm trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #477 of 28,707 conditions by registered trial count.
32 US clinical trials · 21 currently recruiting · #477 of 28,707 conditions by registered trial count
Hematopoietic and Lymphoid System Neoplasm: 32 US clinical trials tracked, 21 recruiting.
Hematopoietic and Lymphoid System Neoplasm is the subject of 32 registered US clinical trials on ClinicalTrials.gov, 21 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 12 of these trials.
Enrollment posture brief
Registry condition hematopoietic-and-lymphoid-system-neoplasm
OPEN 21 | RECR 66% | LATE 2 | EARLY 9 | RANK #477 | SPON 12
Volume-matched condition peers
Nearest open-share peer: Intracerebral Hemorrhage (66% recruiting · 32 trials)
Hematopoietic and Lymphoid System Neoplasm lists 21 open slots (66% of 32 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hematopoietic and Lymphoid System Neoplasm on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hematopoietic and Lymphoid System Neoplasm is recruiting above its size-band peers.
21 of 32 indexed trials (65.6%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Hematopoietic and Lymphoid System Neoplasm research.
Mayo Clinic accounts for 12 of 32 trials (37.5%). 9 distinct sponsors appear on at least one study for this condition label.
-
Typical Hematopoietic and Lymphoid System Neoplasm enrolment sits around 113 participants.
Median target enrolment is 113 among the 32 trials that report a genuine target (sentinel values excluded). 14 of those (43.8%) plan for fewer than 100 participants.
-
Hematopoietic and Lymphoid System Neoplasm research is mostly interventional.
26 interventional and 6 observational studies make up this index (81.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
32 total, page 1 of 1
Identifying and Caring for Individuals With Inherited Cancer Syndrome
OHSU Knight Cancer Institute
NCT04494945
A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)
Mayo Clinic
NCT06192875
A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors (ASCENT)
Mayo Clinic
NCT06198010
Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients
Mayo Clinic
NCT06015932
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
Mayo Clinic
NCT06008392
Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study
City of Hope Medical Center
NCT05772130
Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial
City of Hope Medical Center
NCT06022965
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
City of Hope Medical Center
NCT06059391
Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial
Ohio State University Comprehensive Cancer Center
NCT06314672
Community-Based Physical Activity Intervention for Underserved Cancer Survivors
Roswell Park Cancer Institute
NCT06206863
Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer
Mayo Clinic
NCT06246955
Communication Issues in Patient and Provider Discussions of Immunotherapy
Emory University
NCT05873608
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
Mayo Clinic
NCT06151730
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
M.D. Anderson Cancer Center
NCT03471260
Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients
Roswell Park Cancer Institute
NCT05893940
Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors
Mayo Clinic
NCT05584449
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
Mayo Clinic
NCT05530759
Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
M.D. Anderson Cancer Center
NCT04022239
Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment
Mayo Clinic
NCT07221409
Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy
Mayo Clinic
NCT05411523
Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies
City of Hope Medical Center
NCT05443425
Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking
Fred Hutchinson Cancer Center
NCT04409236
Patient Considerations of Social Media Account Management After Death
M.D. Anderson Cancer Center
NCT05035667
Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant
Fred Hutchinson Cancer Center
NCT04572815
Passive Music Intervention for the Reduction of Anxiety in Patients Undergoing Bone Marrow Aspiration and/or Biopsy
City of Hope Medical Center
NCT06169267
Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer
City of Hope Medical Center
NCT05868486
Physical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent Cancer
M.D. Anderson Cancer Center
NCT03583255
Transcutaneous Sensors for the Detection of Cancer-Related Lymphedema, Project Limb Rescue Study
Ohio State University Comprehensive Cancer Center
NCT06305884
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
GeoVax
NCT04977024
Evaluation of a Couple-Based Physical Activity Intervention
Mayo Clinic
NCT06073951
Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer
Emory University
NCT05346692
Stress Echocardiography to Identify Chemotherapy Induced Cardiotoxicity in Cancer Patients With Heart Failure Risk
Mayo Clinic
NCT05950399
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 4 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Hematopoietic and Lymphoid System Neoplasm records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hematopoietic and Lymphoid System Neoplasm trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hematopoietic and Lymphoid System Neoplasm page
32 registered trials, 21 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 21 Hematopoietic and Lymphoid System Neoplasm trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Mayo Clinic sponsors the most Hematopoietic and Lymphoid System Neoplasm trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hematopoietic and Lymphoid System Neoplasm condition card totals 32 registered trials; most-linked intervention Questionnaire Administration; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.